Legal & General Group PLC G1 Therapeutics, Inc. Transaction History

Legal & General Group PLC

$470 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$2.2 - $4.98 $12,027 - $27,225	5,467 New	5,467 $12,000
Q1 2023 May 15, 2023	SELL	$2.57 - $8.16 $23,677 - $75,178	-9,213 Reduced 79.62%	2,358 $6,000
Q4 2022 Feb 14, 2023	BUY	$5.19 - $13.5 $60,053 - $156,208	11,571 New	11,571 $62,000
Q2 2022 Aug 22, 2022	SELL	$4.04 - $8.51 $80,141 - $168,812	-19,837 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$7.6 - $11.02 $836 - $1,212	110 Added 0.56%	19,837 $150,000
Q4 2021 Feb 14, 2022	BUY	$10.16 - $16.17 $91,297 - $145,303	8,986 Added 83.66%	19,727 $201,000
Q3 2021 Nov 15, 2021	BUY	$13.16 - $22.47 $76,393 - $130,438	5,805 Added 117.61%	10,741 $144,000
Q2 2021 Aug 12, 2021	SELL	$19.57 - $26.32 $1,957 - $2,632	-100 Reduced 1.99%	4,936 $109,000
Q1 2021 May 17, 2021	BUY	$17.58 - $32.59 $8,016 - $14,861	456 Added 9.96%	5,036 $121,000
Q4 2020 Feb 12, 2021	SELL	$10.99 - $20.4 $1,989 - $3,692	-181 Reduced 3.8%	4,580 $83,000
Q3 2020 Nov 13, 2020	SELL	$11.55 - $23.75 $16,250 - $33,416	-1,407 Reduced 22.81%	4,761 $55,000
Q2 2020 Aug 14, 2020	BUY	$9.57 - $24.37 $363 - $926	38 Added 0.62%	6,168 $149,000
Q1 2020 May 14, 2020	SELL	$9.07 - $26.32 $14,049 - $40,769	-1,549 Reduced 20.17%	6,130 $68,000
Q4 2019 Feb 13, 2020	BUY	$20.54 - $31.0 $16,801 - $25,358	818 Added 11.92%	7,679 $203,000
Q3 2019 Nov 13, 2019	BUY	$22.78 - $40.58 $15,695 - $27,959	689 Added 11.16%	6,861 $157,000
Q2 2019 Aug 14, 2019	BUY	$16.03 - $31.1 $33,855 - $65,683	2,112 Added 52.02%	6,172 $189,000
Q4 2018 Feb 15, 2019	BUY	$16.51 - $51.33 $11,160 - $34,699	676 Added 19.98%	4,060 $78,000
Q3 2018 Nov 20, 2018	BUY	$43.15 - $67.97 $5,738 - $9,040	133 Added 4.09%	3,384 $177,000
Q2 2018 Aug 10, 2018	BUY	$35.06 - $51.17 $30,256 - $44,159	863 Added 36.14%	3,251 $141,000
Q1 2018 May 17, 2018	BUY	$19.05 - $41.76 $11,963 - $26,225	628 Added 35.68%	2,388 $88,000
Q4 2017 Feb 13, 2018	BUY	$19.01 - $26.2 $33,457 - $46,112	1,760	1,760 $35,000

Others Institutions Holding GTHX

# of Institutions

Shares Held

3.55M

Call Options Held

11.7K

Put Options Held

View Full List

About G1 Therapeutics, Inc.

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

More about GTHX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account